71 related articles for article (PubMed ID: 1376962)
1. [The evaluation of the effects of bunazosin hydrochloride in the treatment of prostatic hyperplasia].
Fujita T; Ohshima S; Asano H; Ono Y; Kinukawa T; Kato N; Hirabayashi S
Hinyokika Kiyo; 1992 May; 38(5):613-21. PubMed ID: 1376962
[TBL] [Abstract][Full Text] [Related]
2. [A double-blind trial on the effect of bunazosin hydrochloride for the symptoms of benign prostatic hypertrophy].
Kumamoto Y; Tsukamoto T; Yachiku S; Kaneko S; Koyanagi T; Togashi M; Maru A; Tsuchida S; Nishizawa O; Orikasa S
Hinyokika Kiyo; 1990 Oct; 36(10):1213-32. PubMed ID: 1702262
[TBL] [Abstract][Full Text] [Related]
3. [Clinical efficacy of oxendolene (antiandrogen) and bunazosin hydrochloride (alpha-adrenergic blocker) in the treatment of prostatism--comparative study of oxendolone, bunazocin hydrochloride and their combination].
Kumamoto Y; Tsukamoto T; Takagi Y; Furuya S; Yokoyama E; Takatsuka K; Tamiya T; Miyamoto S; Aoyama T; Honma A
Hinyokika Kiyo; 1987 Nov; 33(11):1921-41. PubMed ID: 2451412
[TBL] [Abstract][Full Text] [Related]
4. [A double-blind trial on the effect of alpha-adrenergic blocker (bunazosin hydrochloride) in the symptomatic treatment of prostatism].
Kumamoto Y; Yokoyama E; Tsukamoto T; Tsuchida S; Nishizawa O; Koshiba K; Ishibashi A; Ogawa A; Tomita Y; Aso Y
Hinyokika Kiyo; 1987 Oct; 33(10):1681-702. PubMed ID: 2451409
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of bunazosin hydrochloride for the treatment of voiding disturbances due to neurogenic bladder--a double-blind study].
Koyanagi T; Togashi M; Maru A; Orikasa S; Soma F; Shimazaki J; Yasuda K; Aso Y; Honma Y; Miyake K
Hinyokika Kiyo; 1990 Oct; 36(10):1233-52. PubMed ID: 1979900
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of bunazosin hydrochloride, an alpha 1-adrenergic blocker, in benign prostatic obstruction and neurogenic bladder dysfunction].
Takita T; Kondo A; Mitsuya H; Otani T
Hinyokika Kiyo; 1987 Sep; 33(9):1375-84. PubMed ID: 2449057
[TBL] [Abstract][Full Text] [Related]
7. [The effect of moxisylyte hydrochloride in the symptomatic treatment of benign prostatic hyperplasia].
Izumi H; Kudo S; Fuino A; Yokoyama E; Ishibashi A
Hinyokika Kiyo; 1989 Mar; 35(3):541-9. PubMed ID: 2472054
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness and safety of bunazosin hydrochloride in neurogenic bladder after prolonged administration].
Hiraga S; Satoh T; Kakehi R; Kojima S; Yokokawa M; Gotoh S; Kaneoya F; Mizuo T; Tanizawa A; Hosoda K
Hinyokika Kiyo; 1992 Feb; 38(2):255-63. PubMed ID: 1348604
[TBL] [Abstract][Full Text] [Related]
9. Effects of short-term treatment with the alpha 1-blocker alfuzosin on urodynamic pressure/flow parameters in patients with benign prostatic hyperplasia.
Martorana G; Giberti C; Di Silverio F; von Heland M; Rigatti P; Colombo R; Casadei G; Pacifico P
Eur Urol; 1997; 32(1):47-53. PubMed ID: 9266231
[TBL] [Abstract][Full Text] [Related]
10. [A multicenter, fixed-flexible dose study of terazosin hydrochloride in the treatment of symptomatic benign prostatic hypertrophy].
Park YC; Nishioka T; Arai Y; Tomoyoshi T; Kurita T; Hayashida H; Nagai N; Inoue H; Kataoka K; Kitagawa Y
Hinyokika Kiyo; 1992 Jul; 38(7):857-68. PubMed ID: 1381869
[TBL] [Abstract][Full Text] [Related]
11. Alfuzosin in the treatment of benign prostatic hyperplasia: effects on symptom scores, urinary flow rates and residual volume. A multicentre, double-blind, placebo-controlled trial. ALFECH Study Group.
Hansen BJ; Nordling J; Mensink HJ; Walter S; Meyhoff HH
Scand J Urol Nephrol Suppl; 1994; 157():169-76. PubMed ID: 7524141
[TBL] [Abstract][Full Text] [Related]
12. [The treatment of patients with benign prostatic hyperplasia using the selective alpha-blocker alfuzosin].
Mazo EB; Matushevskiĭ IA; Nikitin IuIu
Ter Arkh; 1997; 69(10):79-82. PubMed ID: 9471799
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
[TBL] [Abstract][Full Text] [Related]
14. [Doxazosin in the gastrointestinal therapeutic system (GITS) and doxazosin standard in patients with benign prostatic hyperplasia. Double-blind trial of efficacy and tolerability].
Gratzke P; Kirby RS
Fortschr Med Orig; 2000 Jul; 118 Suppl 2():83-92. PubMed ID: 15700491
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 25 and 75 mg/day naftopidil for lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective, randomized controlled study.
Yokoyama T; Kumon H; Nasu Y; Takamoto H; Watanabe T
Int J Urol; 2006 Jul; 13(7):932-8. PubMed ID: 16882058
[TBL] [Abstract][Full Text] [Related]
16. [The efficacy of alfuzosin (dalfaz) in patients with benign prostatic hyperplasia].
Tkachuk VN; Kuz'min IV
Urol Nefrol (Mosk); 1998; (2):38-40. PubMed ID: 9577703
[TBL] [Abstract][Full Text] [Related]
17. [Safety ov benign prostatic hyperplasia treatment with alpha-adrenoblocker dalphas].
Loran OB; Pushkar' DIu; Rasner PI
Urologiia; 2000; (2):3-5. PubMed ID: 11186726
[TBL] [Abstract][Full Text] [Related]
18. [Efficiency and tolerance of terazosine in ambulatory patients with benign prostatic hypertrophy: comparative randomized and double-blind trial versus alfuzosin. The MG Terazosine Group].
Fourcade RO
Prog Urol; 2000 Apr; 10(2):246-53. PubMed ID: 10857142
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of two alpha-adrenoreceptor antagonists, doxazosin and alfuzosin, in patients with lower urinary tract symptoms from benign prostatic enlargement.
de Reijke TM; Klarskov P
BJU Int; 2004 Apr; 93(6):757-62. PubMed ID: 15049986
[TBL] [Abstract][Full Text] [Related]
20. Rapid onset of action with alfuzosin 10 mg once daily in men with benign prostatic hyperplasia: a randomized, placebo-controlled trial.
Resnick MI; Roehrborn CG
Prostate Cancer Prostatic Dis; 2007; 10(2):155-9. PubMed ID: 17211442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
